At our practice, we tailor treatment plans to each patients unique health profile, preferences, and goals
In an upcoming hearing in May 2025, the judge overseeing these GLP-1 will decide what experts can speak at the test trials
Blood sugar can matter for some people GLP1 medications alone are unlikely to cause dangerously low blood sugar, but risk increases when they are combined with insulin or sulfonylureas
Clinical trials did not mandate morning or evening dosing
Step 4: Ongoing monitoring and support Follow-up visits and unlimited messaging allow adjustments as progress evolves
Common: nausea (especially during dose increasesusually mild and transient), constipation or diarrhea, occasional vomiting, fatigue in first weeks, decreased appetite (the desired effect, but worth noting)